Trial · NCT01236560
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Feasibility (Vorinostat) | 6 | |
| Overall Study | STARTED | Arm I (Vorinostat, Phase II Arm A) | 32 | |
| Overall Study | STARTED | Arm II (Temozolomide, Phase II Arm B) | 31 | |
| Overall Study | STARTED | Arm III (Bevacizumab, Phase II Arm C) | 32 | |
| Overall Study | STARTED | Arm IV (Temozolomide, Phase III Arm B) | 0 | |
| Overall Study | STARTED | Arm V (Vorinostat/Bevacizumab, Phase III, Chemoradiotherapy | 0 | |
| Overall Study | COMPLETED | Feasibility (Vorinostat) | 1 | |
| Overall Study | COMPLETED | Arm I (Vorinostat, Phase II Arm A) | 8 | |
| Overall Study | COMPLETED | Arm II (Temozolomide, Phase II Arm B) | 11 | |
| Overall Study | COMPLETED | Arm III (Bevacizumab, Phase II Arm C) | 10 | |
| Overall Study | COMPLETED | Arm IV (Temozolomide, Phase III Arm B) | 0 | |
| Overall Study | COMPLETED | Arm V (Vorinostat/Bevacizumab, Phase III, Chemoradiotherapy | 0 | |
| Overall Study | NOT COMPLETED | Feasibility (Vorinostat) | 5 | |
| Overall Study | NOT COMPLETED | Arm I (Vorinostat, Phase II Arm A) | 24 | |
| Overall Study | NOT COMPLETED | Arm II (Temozolomide, Phase II Arm B) | 20 | |
| Overall Study | NOT COMPLETED | Arm III (Bevacizumab, Phase II Arm C) | 22 | |
| Overall Study | NOT COMPLETED | Arm IV (Temozolomide, Phase III Arm B) | 0 | |
| Overall Study | NOT COMPLETED | Arm V (Vorinostat/Bevacizumab, Phase III, Chemoradiotherapy | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01236560/flow